Roger S. McIntyre on Muck Rack

Roger S. McIntyre

Toronto
As seen in: Color Research & Application, Wiley Online Library, Cambridge University Press & Assessment, Memory Studies, Educational Studies, Evidence-Based Mental Health, MDPI, Taylor & Francis Online, JAMA (The Journal of the American Medical Association), JAMA Psychiatry and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Roger S.

Contact Roger S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode : A Systematic Review and Meta-Analysis

|
By Sung Ryul Shim, Hye Jeong, Tanner Bommersbach, Andrew A Nierenberg, Carlos A. Zarate, Tyler S Kaster, Christoph U. Correll, Roger S. McIntyre, John H Krystal, Taeho Greg Rhee
| JAMA Psychiatry Verified
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis Key Points Question Is intravenous ketamine efficacious in reducing suicidal and depressive symptoms in patients with a major depressive episode (MDE)?
Open in Who Shared Issue with article?

Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder : A Randomized Clinical Trial

|
By Hartej Gill, Sebastian Badulescu, Ryan M. Brudner, Lee Phan, Joshua Di Vincenzo, Aniqa Tabassum, Sharmili Edwin Thanarajah, Cristian-Daniel Llach, Joshua Rosenblat, Roger S. McIntyre, Rodrigo B. Mansur, Hiya Shah
| JAMA Psychiatry Verified
Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial Key Points Question Does oral semaglutide improve reward-related dysfunction in a clinical population with major depressive disorder (MDD)? Findings In this 16-week, double-blind, placebo-controlled, parallel-group, fixed-dose randomized clinical trial, semaglutide-treated participants exhibited a pattern of increased willingness to exert physical efforts with higher expected values of reward.
Open in Who Shared Issue with article?

Adjunctive Antipsychotics in Major Depressive Disorder : A Systematic Review and Network Meta-Analysis

|
By Roger S. McIntyre, Stephen Stahl, Sung Ryul Shim, Maurizio Pompili, Joseph F. Goldberg, Christoph U. Correll, Angela Kwan, Christine E. Dri, Taeho Greg Rhee, Heidi Xu
| JAMA Psychiatry Verified
Adjunctive Antipsychotics in Major Depressive Disorder: A Systematic Review and Network Meta-Analysis Key Points Question How do US Food and Drug Administration (FDA)–approved atypical antipsychotics in major depressive disorder (MDD) compare with respect to overall efficacy and acceptability?
Open in Who Shared Issue with article?
See all 55 licensed articles (126 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified